Viridian Therapeutics, Inc. (VRDN)
17.26
-0.27
(-1.54%)
USD |
NASDAQ |
May 07, 15:27
Viridian Therapeutics Free Cash Flow : -304.30M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Boston Scientific Corp. | 3.475B |
| Marker Therapeutics, Inc. | -12.01M |
| Plus Therapeutics, Inc. | -20.84M |
| Nutriband, Inc. | -5.140M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -119.65M |
| Cash from Investing (Quarterly) | 77.26M |
| Cash from Financing (Quarterly) | 6.357M |
| Free Cash Flow Per Share (Quarterly) | -1.171 |
| Free Cash Flow to Equity (Quarterly) | -120.16M |
| Free Cash Flow to Firm (Quarterly) | -116.22M |
| Free Cash Flow Yield | -19.59% |